| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jun 15, 2026 | Sell(S) | 9K | $45.02 | $409K | 246K |
| Jun 15, 2026 | Sell(S) | 272K | $45.02 | $12.3M | 7.4M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-26-000637) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Enliven Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.